| [1] |
Nguyen L, Besson A, Heng J I, et al. P27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev,2006,20:1511 -1524.
|
| [2] |
Zhang W G, Wu Q M, Yu J P, et al. Adenovirus expressing p27kip1 suppresses growth of established esophageal carcinoma xenografts. World J Gastroenterol,2005,11:6582 -6586.
|
| [3] |
Hsu Y L, Kuo P L, Tzeng W S, et al. Chalcone inhibits the proliferation of human breast cancer cell by blocking cell cycle progression and inducing apoptosis. Food Chem Toxicol,2006,44:704 -713.
|
| [4] |
Xing H, Wang S, Hu K, et al. Effect of the cyclin-dependent kinases inhibitor P27 on resistance of ovarian cancer multicellular spheroids to anticancer chem-otherapy. J Cancer Res Clin Oncol,2005,131:511-519.
|
| [5] |
Deans AJ, Simpson K J,Trivett M K,et al. Brca1 inactivation induces p27Kip1 dependent cell cycle arrest and delayed development in the mouse mammary gland. Oncogene,2004,23:6136 -6145.
|
| [6] |
Murray S A, Yang S, Demicco E, et al. Increased expression of MDM2, cyclin D1, and p27 kip1 in carcinogen induced rat mammary tumors. J Cell Biochem,2005,95:875 -884.
|
| [7] |
Naidu R, Har Y C, Taib N A, et al. P27 V109G polymorphism is associated with lymph node metastases but not with increased risk of breast cancer. J Exp Clin Cancer Res,2007,26:133 -140.
|
| [8] |
Figueiredo J C, Knight J A, Cho S, et al. Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis. BMC Cancer,2007,14:99 -107.
|
| [9] |
Kourea H P, Koutras A K, Zolota V, et al. Expression of p27kipP1, p21WAF1 and p53 does not correlate with prognosis in node-negative invasive ductal carcinoma of the breast.Anticancer Res,2006,26:1657 -1668.
|
| [10] |
Paruthiyil S, Parmar H, Kerekatte V, et al. Estrogen receptor beta inhibitsHuman breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res,2004,64:423 -428.
|
| [11] |
Millar EK, Tran K, Marr P, et al. p27kip-1 cyclin A and cyclin D1 protein expression in ductal carcinoma in situ of the breast: p27kip-1 correlates with hormone receptor status but not with local recurrence. Pathology Int,2007,57:183 -189.
|
| [12] |
令华,刘巍,宋丽楠,等. BCSG1、C-erbB-2、VEGF 表达与乳腺癌临床病理因素相关性研究. 中华乳腺病杂志(电子版),2007,1:82 -86.
|
| [13] |
Zhang Y, Yang H Y,Zhang X C,et al. Tumor suppressor ARF inhibits HER-2/neu mediated oncogenic growth. Oncogene,2004,23:7132-7143.
|
| [14] |
Yang H, Zhao R, Yang H Y, et al. Constitutively active FOXO4 inhibits Akt activity, regulates p27kip1 stability, and suppresses HER-2-mediated tumorigeni-city. Oncogene,2005,24:1924 -1935.
|
| [15 |
] Tsutsui S, Inoue H, Yasuda K, et al. Inactivation of PTEN is associated with low p27kip1 protein expression in breast carcinoma. Cancer,2005,104:2048 -2053.
|
| [16] |
Traub F, Mengel M,Luck H J, et al. Prognostic impact of Skp2 and p27 in human breast cancer. Breast Cancer Res Treat,2006,99:185 -191.
|
| [17] |
Tsutsui S,Yasuda K,Suzuki K,et al. Bcl-2 protein expression is associatedwith p27 and p53 protein expressions and MIB-1 counts in breast cancer. BMC Cancer,2006,6:187 -194.
|
| [18] |
Spataro V J, Litman H, Viale G, et al. Decreased immunoreactivity for p27 protein in patients with early stage breast carcinoma is correlated with HER-2/neu over expression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V. Cancer,2003,97:1591 -1600.
|
| [19] |
Porter P L, Barlow W E, Yeh I T, et al. p27(kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy. J Natl Cancer Inst, 2006,98:1723 -1731.
|
| [20] |
Carrol J S, Lynch D K, Swarbrick A, et al. P27kip1 induces quiescence and growth factor insensitivity in tamoxifen-treated breast cancer cells. Cancer Res,2003,63:4322 -4326.
|
| [21] |
Chu I, Sun J, Arnaout A, et al. P27 phosphorylatin by src regulates inhibitionOf cyclin E-Cdk2. Cell,2007,128:281-294.
|
| [22] |
Nahta R, Takahashi T, Ueno N, et al. P27kip1 down regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res,2004,64:3981 -3986.
|
| [23] |
Le X F,Pruefer F,Bast RC J R,et al. HER-2-targeting antibodies modulate the cyclin dependent kinase inhibitor p27 kip1 via multiple signaling pathways.Cell Cycle,2005,4:87-95.
|
| [24] |
Zhang Q, Tian L, Mansouri A,et al. Inducible expression of a degradation resistant form of p27kip1 causes growth arrest and apoptosis in breast cancer cells. FEBS Lett,2005,579:3932 -3940.
|
| [25] |
Yang H, Yang H, Zhao R, et al. Modified p27 kip1 is efficient in suppressing HER-2-mediated tumorigenicity. J Cell Biochem,2006,98:128 -138.
|